-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QpkADGw3QPjEZD/ayxi4KJ3d6E9xihu64jP856EBGNsEkwHqfDVoHosTX7/aPxwi sje1b70frO7dxf6uJ5I4Cg== 0001179110-05-016671.txt : 20050818 0001179110-05-016671.hdr.sgml : 20050818 20050818211610 ACCESSION NUMBER: 0001179110-05-016671 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050817 FILED AS OF DATE: 20050818 DATE AS OF CHANGE: 20050818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W CENTRAL INDEX KEY: 0001190273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 051036945 BUSINESS ADDRESS: BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR STREET 2: C/O GILEAD SCIENCES, INC. CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0202 4 2005-08-17 0 0000882095 GILEAD SCIENCES INC GILD 0001190273 BISCHOFBERGER NORBERT W 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, Research Common Stock 2005-08-17 4 M 0 13704 7.2969 A 491573 D Common Stock 2005-08-17 4 M 0 110000 7.3985 A 601573 D Common Stock 2005-08-17 4 S 0 20000 42.22 D 581573 D Common Stock 2005-08-17 4 S 0 30000 42.12 D 551573 D Common Stock 2005-08-17 4 S 0 10000 42.11 D 541573 D Common Stock 2005-08-17 4 S 0 50000 42.10 D 491573 D Common Stock 800 I by Daughter Common Stock 800 I by Son Common Stock 92322 I by Trust Incentive Stock Option (right to buy) 7.2969 2005-08-17 4 M 0 13704 0 D 2009-07-21 Common Stock 13704 0 D Non-Qualified Stock Option (right to buy) 7.3985 2005-08-17 4 M 0 110000 0 D 2011-01-17 Common Stock 110000 196488 D Amount of Securities Beneficially Owned at End of Month (Table 1, Col. 5) includes 719 shares acquired on 6/30/05 under the Gilead Sciences, Inc. Employee Stock Purchase Plan. Options vested 20% on 7/22/2000, the first anniversary date of the grant, and the remaining balance vested quarterly over the next four years. The option was fully vested as of 7/22/04. Options vested 20% on 1/18/02, the first anniversary date of the grant, and the remaining balance vests quarterly over the next four years. The option will be fully vested by 1/18/06. /s/ Matthew K. Au as power of attorney for Norbert W. Bischofberger 2005-08-18 EX-24.TXT 2 poa-bischofberger_new.txt POWER OF ATTORNEY AUTHORIZATION LETTER May 13, 2005 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Attn: Filing Desk To Whom It May Concern: By means of this letter I authorize Mark L. Perry, John F Milligan, Gregg H. Alton, ESQ., and MAtthew K. Au, or any of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock of derivative securities of Gilead Sciences, Inc. (the "Company"). Any of these individuals is accordingly authorized to sign any Form 3, Form 4, Form 5 or amendment thereto which I am required to file with the same effect as if I had signed them myself. This authorization shall remain in effect until revoked in writing by me. Yours truly, /s/ Norbert W. Bischofberger POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Mark L. Perry, John F. Milligan, Gregg H. Alton, Esq., and MAtthew K. Au, signing individually, the undersigned's true and lawful attorneys-in-fact and agents to: (1) execute for and on behalf of the undersigned, an officer or director of Gilead Sciences, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute such Form 3, 4 or 5, complete and execute and amendment or amendments thereto, and timely file such forms or amendments with United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any nature whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney- in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, fully to all intents and purpose as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorney's-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact shall no longer be employed by the Company. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 13th day of May 2005. _/s/ Norbert W. Bischofberger -----END PRIVACY-ENHANCED MESSAGE-----